Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: The effect of anti-IL-6 receptor antibody for the treatment of McH-lpr/lpr-RA1 mice that spontaneously developed destructive arthritis and enthesitis

Fig. 1

ELISA assays for SAA and IL-6. a ELISA assay for SAA at week 14 and 17. Serum SAA level is significantly lower in MR16–1 treated group at week 17. b ELISA assay for IL-6 at week 14 and 17. There is no significant difference in serum IL-6 level. Results are expressed as the mean ± standard error (n = 5 mice per group). Representative data are shown from three independent experiments with similar results. *p < 0.05 by two-way ANOVA with Dunn’s multiple comparison test

Back to article page